ArticlePeerJ2020
COVID-19: molecular and serological detection methods.
Article in PeerJ, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Article
- Deep-Learning-Based COVID-19 Diagnosis and Implementation in Embedded Edge-Computing Device.Diagnostics (Basel, Switzerland) · 2023Article
- Diagnosis of SARS-CoV-2 during the Pandemic by Multiplex RT-rPCR hCoV Test: Future Perspectives.Pathogens (Basel, Switzerland) · 2022Article
- A Short Review Comparing Carbon-Based Electrochemical Platforms With Other Materials For Biosensing SARS-Cov-2.ChemistrySelect · 2022Review
- Bacterial ligands as flexible and sensitive detectors in rapid tests for antibodies to SARS-CoV-2.Analytical and bioanalytical chemistry · 2022Article
- An AIEgen/graphene oxide nanocomposite (AIEgen@GO)-based two-stage "turn-on" nucleic acid biosensor for rapid detection of SARS-CoV-2 viral sequence.Aggregate (Hoboken, N.J.) · 2022Article
- SARS-CoV-2 in wastewater: From detection to evaluation.Materials today. Advances · 2022Review
- Towards application of CRISPR-Cas12a in the design of modern viral DNA detection tools (Review).Journal of nanobiotechnology · 2022Review
- Biosensors for the Determination of SARS-CoV-2 Virus and Diagnosis of COVID-19 Infection.International journal of molecular sciences · 2022Review
- Detection of SARS-CoV-2 Genome in Stool and Plasma Samples of Laboratory Confirmed Iranian COVID-19 Patients.Frontiers in molecular biosciences · 2022Article
- Diagnostic evaluation of qRT-PCR-based kit and dPCR-based kit for COVID-19.Genes & genomics · 2021Article
- Biochemical composition, transmission and diagnosis of SARS-CoV-2.Bioscience reports · 2021Review
- Testing for COVID-19 in dental offices: Mechanism of action, application, and interpretation of laboratory and point-of-care screening tests.Journal of the American Dental Association (1939) · 2021Review
- The SARS-CoV-2 viral load in COVID-19 patients is lower on face mask filters than on nasopharyngeal swabs.Scientific reports · 2021Article
- Affinity Sensors for the Diagnosis of COVID-19.Micromachines · 2021Review
- COVID-19: advance in laboratory diagnostic strategy and technology.Molecular and cellular biochemistry · 2021Review
- Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms.Frontiers in cellular and infection microbiology · 2021Article
- Antigen tests for COVID-19.Biophysics and physicobiology · 2021Article
- Editorial: 2020: The Year of The COVID-19 Pandemic.The journal of nutrition, health & aging · 2021Article
- Potential of artificial intelligence to accelerate diagnosis and drug discovery for COVID-19.PeerJ · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared as a pandemic disease by the World Health Organization in early 2020, many countries, organizations and companies have tried to find the best way to diagnose the virus and contain its spreading. SARS-CoV-2 is a positive-sense single RNA (+ssRNA) coronavirus and mainly spreads through droplets, respiratory secretions, and direct contact. The early detection of the virus plays a central role in lowering COVID19 incidents and mortality rates. Thus, finding a simple, accurate, cheap and quick detection approach for SARS-CoV-2 at early stage of the viral infection is urgent and at high demand all around the world. The Food and Drug Administration and other health agencies have declared Emergency Use Authorization to develop diagnostic methods for COVID-19 and fulfill the demand. However, not all developed methods are appropriate and selecting a suitable method is challenging. Among all detection methods, rRT-PCR is the gold standard method. Unlike molecular methods, serological methods lack the ability of early detection with low accuracy. In this review, we summarized the current knowledge about COVID-19 detection methods aiming to highlight the advantages and disadvantages of molecular and serological methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.